Assessment of Minimum Inhibitory Concentrations of Telavancin by Revised Broth Microdilution Method in Phase 3 Hospital-Acquired Pneumonia/Ventilator-Associated Pneumonia Clinical Isolates.

about

Dosing strategies to optimize currently available anti-MRSA treatment options (Part 1: IV options).

P2860

Q38907793-B0B83ECD-C171-4A2C-AC85-AAFA67EDB425

P2860

Assessment of Minimum Inhibitory Concentrations of Telavancin by Revised Broth Microdilution Method in Phase 3 Hospital-Acquired Pneumonia/Ventilator-Associated Pneumonia Clinical Isolates.

Item

http://www.wikidata.org/entity/Q40513210

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Assessment of Minimum Inhibito ...... d Pneumonia Clinical Isolates.

@en

type

Item

label

Assessment of Minimum Inhibito ...... d Pneumonia Clinical Isolates.

@en

prefLabel

Assessment of Minimum Inhibito ...... d Pneumonia Clinical Isolates.

@en

P1476

Assessment of Minimum Inhibito ...... d Pneumonia Clinical Isolates.

@en

P2093

Gordon Ralph Corey

http://www.w3.org/2001/XMLSchema#string

Jennifer I Smart

http://www.w3.org/2001/XMLSchema#string

Martin E Stryjewski

http://www.w3.org/2001/XMLSchema#string

Steven L Barriere

http://www.w3.org/2001/XMLSchema#string

Whedy Wang

http://www.w3.org/2001/XMLSchema#string

P2860

Telavancin, a multifunctional lipoglycopeptide, disrupts both cell wall synthesis and cell membrane integrity in methicillin-resistant Staphylococcus aureus

Two-sided confidence intervals for the single proportion: comparison of seven methods

High vancomycin minimum inhibitory concentration and clinical outcomes in adults with methicillin-resistant Staphylococcus aureus infections: a meta-analysis.

Staphylococcus aureus infections: epidemiology, pathophysiology, clinical manifestations, and management.

Telavancin versus vancomycin for hospital-acquired pneumonia due to gram-positive pathogens.

Comparison of dalbavancin MIC values determined by Etest (AB BIODISK) and reference dilution methods using gram-positive organisms.

Management of Adults With Hospital-acquired and Ventilator-associated Pneumonia: 2016 Clinical Practice Guidelines by the Infectious Diseases Society of America and the American Thoracic Society.

Relationship between vancomycin MIC and failure among patients with methicillin-resistant Staphylococcus aureus bacteremia treated with vancomycin.

Telavancin: mechanisms of action, in vitro activity, and mechanisms of resistance.

Telavancin activity tested against Gram-positive clinical isolates from European, Russian and Israeli hospitals (2011-2013) using a revised broth microdilution testing method: redefining the baseline activity of telavancin.

P2888

s40121-016-0133-y

P304

535-544

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S40121-016-0133-Y

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-10-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27718118

http://www.w3.org/2001/XMLSchema#string

P921

ventilator

P932

5125136

http://www.w3.org/2001/XMLSchema#string

Assessment of Minimum Inhibitory Concentrations of Telavancin by Revised Broth Microdilution Method in Phase 3 Hospital-Acquired Pneumonia/Ventilator-Associated Pneumonia Clinical Isolates.

about

P2860

P2860

Assessment of Minimum Inhibitory Concentrations of Telavancin by Revised Broth Microdilution Method in Phase 3 Hospital-Acquired Pneumonia/Ventilator-Associated Pneumonia Clinical Isolates.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P698

P921

P932